Medical Marijuana. Medicalization of Marijuana. Objectives. Disclosure. Objectives. US FDA Drug Approval Process

Similar documents
Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

Medical Cannabis MATT WEBSTER DO, MS

Medical Marijuana Consent Form

Federal Law: Marijuana

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Cannabinoids (CB): Outline. CB: Epidemiology. CB: Categorization. CB: Pharmacodynamics. Part #1: Cannabinoid (CB) Primer.

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

The Shifting Federal Regulation of Cannabis Products

The Return of Medicinal Cannabis

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Marijuana and the Chronic Non-Cancer Pain Patient

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

Medicinal Marijuana: The Canadian Journey

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital

Use of Cannabinoids in Medical Practice

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

Medical Marijuana Update Chris Belletieri, DO

Research on Cannabis and PD: Is there any evidence?

Cannabis Use: Scope of the Issue

Opioid Review and MAT Clinic Marijuana

Northern California Chapter, ACP Update In Medicine

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Act 16 and Medical Cannabis in Pennsylvania

Medical Marijuana. Gina C. Guzman, MD, DBIM, FALU, FLMI. Munich Re US (Life) 17 Nov 2016

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Disclosure. Medical Marijuana Updates. Nothing to disclose

Coalition for Medical Marijuana Research & Education

A look at Marijuana in 2014

Medical vs Recreational Use of Cannabis. 11 th December 2017

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

Medical Marijuana in the Workforce. What This Is...And What It Isn t

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

Requirement for Certification from a Health Care Practitioner. Requirement for Certification from a Health Care Practitioner

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

Arizona Hospice and Palliative Care Organization May 13, Medical Marijuana Impact on EOL Care

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

Marijuana and Health

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Medical Marijuana Myths and Realities

Marijuana as Medicine

Reefer Sanity: Seven Great Myths About Marijuana

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

8/31/2016. Workplace Implications of Marijuana in the US. Goal

History of Medical Cannabis in Nursing

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

Marijuana. Module 4 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

COMIRB Protocol Number: PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH. Dear Fellow Medical Student,

Endocannabinoid System Cannabinoid Drugs

The Cannabis model in Canada and the USA. Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

INTRODUCTION WHAT IS MARIJUANA 2/28/2018

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

SECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)

Research: Medical Cannabis

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician

MINNESOTA S MEDICAL CANNABIS PROGRAM

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

Medical Cannabis: A Patient Primer

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Doris C. Gundersen MD Medical Director Colorado Physician Health Program Colorado Association of Medical Staff Services Conference Estes Park,

Hot Topics in Healthcare Osher Lifelong Learning Institute University of California at San Diego. October 17, 2017

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1

Objectives. Why new drugs? New drugs of abuse: synthetic cannabinoids, stimulants, and 10/14/2015. Describe several new drugs of abuse

Medical Marijuana: Hype versus Evidence

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

Marijuana Science Update

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

The ATTC Network LEARNING OBJECTIVES. Clinical Skills in the Era of Legal Cannabis. Clinical Skills in the Era of Legal Cannabis 6/30/2015

Medical Marijuana. Implications for Driving and the Workplace

CANNABIS FOR THE RHEUMATOLOGIST

WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2

The Scientific Side of Medical Marijuana

Marijuana and cannabinoids

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only


Use of Medical Marijuana in Cancer Treatment & Care

Medical Cannabis. Christine Yoshioka, NP

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

MEDICAL CANNABIS IN MINNESOTA

WHAT TO REMEMBER ABOUT CANNABIS HISTORY

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

Cannabinoids and Mental Health

MARIJUANA & THE EFFECTS ON THE BRAIN

Marijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine

INITIAL PATIENT INTAKE FORM

Transcription:

Objectives Medicalization of Marijuana Joe Spillane Pharm.D., DABAT This is not about recreational marijuana. This is not about the Florida Governor election. This is not about politics at all.. This is not about anything but the medicalization of marijuana. 1 Disclosure Medical Marijuana I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with an organization whose philosophy could potentially bias my presentation http://azcapitoltimes.com/files/2012/12/medical-marijuana.png Objectives Review FDA process & medical marijuana Different cannabinoids: availability, legality Pharmacology and pharmacokinetics Safety and efficacy data Practical implications for Florida US FDA Drug Approval Process Preclinical testing Phase 1: safety healthy volunteers Phase 2: prelim efficacy/ safety patients Phase 3: efficacy/safety more patients 1

Phocomelia http://www.peachridgeglass.com/2012/06/from-texas-wm-radams-microbe-killer http://www.english-online.at/health_medicine/thalidomide/thalidomide-victims.htm http://en.wikipedia.org/wiki/file:elixir_sulfanilamide.jpg http://www.fda.gov/forconsumers/consumerupdates/ucm322856.htm Thalidomide http://www.theguardian.com/society/2012/sep/01/thalidomide-scandal-timeline www.ice-epilepsy.org/wp-content/uploads/oda.png 2

Medical Marijuana http://azcapitoltimes.com/files/2012/12/medical-marijuana.png www.greencultured.co 16 Forward to the Past? Microbe Killer & Dr. Siblers Reanimating Solar Tincture 1906 Pure Food & Drug Act 1937 Sulfanilamide Elixir Food Drug & Cosmetic Act Drug Safety 1957 Thalidomide & Phocomelia Keefauer- Harris Act Drug Efficacy 1983 Orphan Drug Act 2014 Medical Marijuana www.politifact.com 17 http://tokesignals.com/wp-content/uploads/2013/10/cannabismedicine.jpg hometestingblog.testcountry.com 18 3

Synthetic Cannabinoids Onset/Duration Onset=10mins after inhalation Variable duration Clinical presentation: Tachycardia, anxiety, psychomotor agitation Tremulousness, palpitations Reddened conjunctiva Increased appetite withdrawal Synthetic Cannabinoids Acute kidney Injury: Mr. Happy case report XLR-11 & UR-144 MMWR cases-16 with AKI-teens, sr cr=3-21mg/dl 5 required dialysis Clown Loyal, Phantom Wicked Dreams, Spice Gold Fatal toxicity 4 cases in Iowa 2013 (5F-PB-22) http://www.700mountains.org/2013/06/karakoram-range-the-ultimatedanger/ Clin Tox 2013;51:189-90. MMWR 2013;62(6):93-97. J Analyt Tox 2014;1-4. Synthetic Cannabinoids Manufacture/Sales Synthetic cannabinoids from Asia Sprayed on to herbal mixture dusting Internet sales not for human consumption Users: Teens and young adults Military Route of administration: smoked/inhaled ingested Different Smokes, Different Tokes Dronabinol (Marinol) Synthetic THC FDA approved in 1985 Chemo N&V AIDS wasting Onset= 30mins-1hr Peak effect=2-4hrs Duration=4-6hrs Prescription medication (CIII) 24 4

Different Smokes, Different Tokes Nabilone (Cesamet) Synthetic racemic mix THC/CBD FDA approved in 1985, marketed in 2006 Chemo N&V AIDS wasting 20% bioavail after 1 st pass effect 1mg capsules Prescription medication (CII) Pharmacother 2013;33(2):195-209. 25 Different Smokes, Different Tokes Other Cannabinoids Anandamide Rimonabant Tetrahydrocannabivirin Delta 8-THC Cannabinol Cannabichromene Cannabigerol Cannafattygetmehigh 28 Different Smokes, Different Tokes Nabiximols (Sativex) Oral mucosal liquid spray THC and CBD 2.7mg THC/spray 2.5mg CBD/spray Not yet FDA approved Neuropathic pain, spasticity Overactive bladder Derived from cannabis sativa plant 26 29 Different Smokes, Different Tokes Cannabadiol (Epiodiolex) Inverse agonist Decreases psychotropic effects of THC Enhances anandamide effect Oral liquid form Not yet FDA approved(orphan drug) Lenox-Gestaut Syndrome Dravets Syndrome Pharmacother 2013;33(2):195-209. 27 http://larraque.livejournal.com/62377.html 30 5

Marijuana Pharmacokinetics Clinical Manifestations Oral: Bioavailability=5-20% (absorption-delayed/incomplete) Peak concentrations 1-3hrs,duration-5-8hrs Smoking: 50% of THC becomes smoke 50% of inhaled smoke is exhaled Estimated smoked bioavailability=10-25% Rapid absorption,pk-30mins,duration-2-3hrs VAPORIZATION Relaxation, sedation, decreased alertness Exaggerated mood & personality Analgesia Tachycardia Increased hunger Red eyes Coughing 31 34 Marijuana Pharmacology Mechanism of Action: CB receptors & anandamide basal ganglia/cerebellum-motor act/coord hippocampus-short term memory limbic-reward system neocortex-thinking, hypothalamus-appetite 32 Use of Marijuana for Certain Medical Conditions Allows the medical use of marijuana for individuals with debilitating diseases as determined by a licensed Florida physician. Allows caregivers to assist patients medical use of marijuana. The Department of Health shall register and regulate centers that produce and distribute marijuana for medical purposes and shall issue identification cards to patients and caregivers. Applies only to Florida law. Does not authorize violations of federal law or any non-medical use, possession or production of marijuana. 35 Debilitating Diseases Cancer, AIDS/HIV+ Glaucoma Hepatitis C Crohn s disease ALS Parkinson s, Multiple Sclerosis 33 http://headsup.scholastic.com/articles/the-science-of-marijuana 36 6

Medical Marijuana Efficacy Neurological Disorders Medical Marijuana Safety Spasiticity: effective/ probably effective Painful spasms: effective/ probably effective Urinary dysfunction: probably ineffective Tremor: probably ineffective Parkinsons: probably ineffective Epilepsy: unknown efficacy Smoked marijuana= unknown efficacy COMPARATIVE EFFICACY-unknown Neurology 2014;82:1556-1563. 37 Addiction: 9% become addicted 17% of teens Cannabis withdrawal Mental Illness: w/ preexisting genetic vulnerability accelerates course of dz unproven causality NEJM 2014;370;23:2219-2227 J Am Acad Child Adolesc Psych 2012;51(7):694-702. 40 Medical Marijuana Efficacy Pain Medical Marijuana Safety Brit J Clin Pharm: Excellent quality of trials Safe and mod effective Amer Acad Pain Medicine: 18 trial meta analysis Mod efficacy for chronic pain Short term trials/methodologic flaws Benefits offset by harms Pain Med 2009;10(8):1353-68. Br J Pharmacol 2011;72(5): 735-44. 38 Cancer & Lung Disease: lower risk of lung cancer than w/tobacco increased risk of chronic bronchitis increase risk of resp. dz Motor Vehicle Accidents: increased THC blood levels=driver impairment +THC=3-7x incr risk of MVA EtOH & THC difficult to prevent DUIC--attitudes Clin Chem 2013;59(3):478-492. 41 Medical Marijuana Efficacy Other Debilitating Conditions Medical Marijuana Adolescent Safety Glaucoma: lowers IOP, + testimonials Short duration q3-4hr dosing required=adr s Not recommended by Amer. Glaucoma Society Crohns Disease: some recent evidence Crohns & Colitis Foundation-research+, use now -neg AIDS wasting: probable efficacy Chemotherapy nausea/vomiting: probable efficacy Amer Glaucoma Society Position Statement Marijuana Jampel, Aug 10,2009 Pharmacol 2014;939(1-2):1-3. 39 Risk perception and marijuana use Diversion to adolescents Increased risk of addiction School performance lower grades failure to reach educational goals memory impairment NEJM 2014; 370;23:2219-2227. Ann Epidemiology 2011;21:714-16. 42 7

Medical Marijuana Adolescent Safety Incr freq. & earlier onset schizophrenia Decreased attention Iincreased impulsivity 43 NEJM 2014; 370;23:2219-2227. 46 Monitoring the Future 2013 Lifetime Use-12 th Graders The adolescent brain is different from the adult brain --Dr. Volkow, Director NIDA 2013 Monitoring the Future Survey Florida Youth Substance Abuse 2013 Lifetime Use-12 th Graders 2013 Florida Youth Substance Abuse Survey 8

The Colorado Experience 2000: physicians can recommend mj to people suffering debilitating medical conditions Jan 2009: 5000 registered mj users Mar 2009: shift of federal policy Nov 2009: 30,000 registered mj users Oct 2011: 88,000 registered mj users J Am Acad Child Adolesc Psych 2012;51(7):694-702 52 Use of Marijuana for Certain Medical Conditions A child who reaches age 21 without smoking, abusing alcohol, or using drugs is virtually certain never to do so. --Joseph Califano, Chairman and President National Center on Addiction and Substance Abuse Columbia University Allows the medical use of marijuana for individuals with debilitating diseases as determined by a licensed Florida physician. Allows caregivers to assist patients medical use of marijuana. The Department of Health shall register and regulate centers that produce and distribute marijuana for medical purposes and shall issue identification cards to patients and caregivers. Applies only to Florida law. Does not authorize violations of federal law or any non-medical use, possession or production of marijuana. 53 The Colorado Experience Debilitating Medical Condition Cancer, AIDS/HIV+, Glaucoma Hepatitis C, ALS, Crohn s disease Parkinson s, Multiple Sclerosis ANY OTHER CONDITION FOR WHICH A PHYSICIAN BELIEVES THAT THE MEDICAL USE OF MARIJUANA WOULD LIKELY OUTWEIGH THE POTENTIAL HEALTH RISKS FOR A PATIENT. tiltingthescales.com 51 54 9

Debilitating Medical Condition ANY OTHER CONDITION FOR WHICH A PHYSICIAN BELIEVES THAT THE MEDICAL USE OF MARIJUANA WOULD LIKELY OUTWEIGH THE POTENTIAL HEALTH RISKS FOR A PATIENT. How to Really Medicalize Marijuana Allow, advocate, and expedite research Ensure access to research medications Provide reasonable dosing/routes of admin. Don t circumvent the US drug approval process Treat medicine like medicine!!!! 55 Marijuana is the ONLY Prescription Medication. to be approved by popular opinion to be approved for use without scientific scrutiny to be smoked to have no standardized dose, concen, composition to be recommended not prescribed to require no monitoring (no interxns, no SE s) to require no counseling or education 56 http://blog.supermedia.com/media/questions.jpg Marijuana is the ONLY Prescription Medication. to have its own distribution system (separate and distinct from pharmacy) for which a recall would be essentially impossible with immunity for physicians with immunity for caregivers with no training required for caregivers with immunity for producers and distributors to require a Florida constitutional amendment 57 10